“RACE for Children Act” is raising hope for new therapies for pediatric cancer. A recent article in The Wall Street Journal discusses exciting trials that are occurring as a result of the RACE. According to the article, many pharmaceutical companies are already gearing up for more studies. As a result, some pediatric trails may be as early as this year!
Crystal Mackall, researcher and professor of pediatrics at Stanford University School of Medicine, told The Wall Street Journal, “We have lots of drug companies who want to speak with us suddenly. Before, we went hat in hand, cajoling.” And, Dr. Hubert Caron of Roche Pharmaceuticals called the legislation “a game-changer.”